Cytta Corp.
CYCA
$0.0234
-$0.0006-2.50%
| Weiss Ratings | CYCA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | CYCA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CYCA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.63 | |||
| Price History | CYCA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.43% | |||
| 30-Day Total Return | -4.88% | |||
| 60-Day Total Return | -18.75% | |||
| 90-Day Total Return | 6.36% | |||
| Year to Date Total Return | -2.50% | |||
| 1-Year Total Return | -13.33% | |||
| 2-Year Total Return | -61.00% | |||
| 3-Year Total Return | -91.17% | |||
| 5-Year Total Return | -6.40% | |||
| 52-Week High % Change | -40.00% | |||
| 52-Week Low % Change | 41.18% | |||
| Price | CYCA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.04 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Apr 24, 2024 | |||
| 52-Week High Price (Date) | May 16, 2024 | |||
| Valuation | CYCA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 11.29M | |||
| Enterprise Value | 11.72M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -26.09% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -12.00 | |||
| Enterprise Value/Revenue (TTM) | 291.47 | |||
| Price | $0.02 | |||
| Enterprise Value/EBITDA (TTM) | -3.37 | |||
| Enterprise Value/EBIT | -3.33 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CYCA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 469.88M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CYCA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 702 900 7022 | |||
| Address | 5450 West Sahara Avenue Las Vegas, NV 89146 | |||
| Website | cytta.com | |||
| Country | United States | |||
| Year Founded | 2006 | |||
| Profitability | CYCA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -8,761.94% | |||
| Profit Margin | -9,682.58% | |||
| Management Effectiveness | CYCA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -131.72% | |||
| Return on Equity | -- | |||
| Income Statement | CYCA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 40.20K | |||
| Total Revenue (TTM) | 40.20K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 21.80K | |||
| EBITDA (TTM) | -3.48M | |||
| EBIT (TTM) | -3.52M | |||
| Net Income (TTM) | -3.89M | |||
| Net Income Avl. to Common (TTM) | -3.89M | |||
| Total Revenue Growth (Q YOY) | 1,491.67% | |||
| Earnings Growth (Q YOY) | 35.12% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 40.00% | |||
| Balance Sheet | CYCA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.01M | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 1.71M | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -924.60K | |||
| Current Ratio (Q) | 0.631 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 1.79M | |||
| Total Current Liabilities (Q) | 2.71M | |||
| Total Debt (Q) | 1.44M | |||
| Total Liabilities (Q) | 2.71M | |||
| Total Common Equity (Q) | -925.20K | |||
| Cash Flow | CYCA - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -14.70K | |||
| Cash from Financing (TTM) | 2.55M | |||
| Net Change in Cash (TTM) | 617.90K | |||
| Levered Free Cash Flow (TTM) | -927.80K | |||
| Cash from Operations (TTM) | -1.92M | |||
